JP2002502367A5 - - Google Patents

Download PDF

Info

Publication number
JP2002502367A5
JP2002502367A5 JP1998549608A JP54960898A JP2002502367A5 JP 2002502367 A5 JP2002502367 A5 JP 2002502367A5 JP 1998549608 A JP1998549608 A JP 1998549608A JP 54960898 A JP54960898 A JP 54960898A JP 2002502367 A5 JP2002502367 A5 JP 2002502367A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998549608A
Other languages
English (en)
Other versions
JP2002502367A (ja
JP4362638B2 (ja
Filing date
Publication date
Priority claimed from US08/855,616 external-priority patent/US5908861A/en
Application filed filed Critical
Priority claimed from PCT/US1998/010033 external-priority patent/WO1998051308A1/en
Publication of JP2002502367A publication Critical patent/JP2002502367A/ja
Publication of JP2002502367A5 publication Critical patent/JP2002502367A5/ja
Application granted granted Critical
Publication of JP4362638B2 publication Critical patent/JP4362638B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Description

Figure 2002502367
Figure 2002502367
Figure 2002502367
Figure 2002502367
JP54960898A 1997-05-13 1998-05-13 pADPRTインヒビターを用いる炎症および炎症性疾患の処置法 Expired - Fee Related JP4362638B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/855,616 1997-05-13
US08/855,616 US5908861A (en) 1997-05-13 1997-05-13 Methods for treating inflammation and inflammatory disease using pADPRT inhibitors
US09/056,396 1998-04-06
US09/056,396 US6303629B1 (en) 1997-05-13 1998-04-06 Methods for treating inflammation, inflammatory diseases, arthritis and stroke using pADPRT inhibitors
PCT/US1998/010033 WO1998051308A1 (en) 1997-05-13 1998-05-13 METHODS FOR TREATING INFLAMMATION AND INFLAMMATORY DISEASES USING pADPRT INHIBITORS

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009119631A Division JP2009227681A (ja) 1997-05-13 2009-05-18 pADPRTインヒビターを用いる炎症および炎症性疾患の処置法

Publications (3)

Publication Number Publication Date
JP2002502367A JP2002502367A (ja) 2002-01-22
JP2002502367A5 true JP2002502367A5 (ja) 2005-12-08
JP4362638B2 JP4362638B2 (ja) 2009-11-11

Family

ID=26735288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP54960898A Expired - Fee Related JP4362638B2 (ja) 1997-05-13 1998-05-13 pADPRTインヒビターを用いる炎症および炎症性疾患の処置法

Country Status (9)

Country Link
EP (1) EP1009404A4 (ja)
JP (1) JP4362638B2 (ja)
CN (1) CN1198614C (ja)
AU (2) AU745790B2 (ja)
BR (1) BR9809115A (ja)
CA (1) CA2289119C (ja)
IL (1) IL132758A0 (ja)
NZ (1) NZ501650A (ja)
WO (2) WO1998051308A1 (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE261963T1 (de) 1999-01-11 2004-04-15 Agouron Pharma Tricyclische inhibitoren von poly(adp-ribose) polymerasen
ECSP003637A (es) 1999-08-31 2002-03-25 Agouron Pharma Inhibidores triciclicos de poli (adp-ribosa) polimerasas
DE60218458T2 (de) 2001-05-08 2007-11-15 Kudos Pharmaceuticals Ltd. Isochinolinon derivate als parp inhibitoren
JP4500161B2 (ja) 2002-04-30 2010-07-14 クドス ファーマシューティカルズ リミテッド フタラジノン誘導体
GB0305681D0 (en) 2003-03-12 2003-04-16 Kudos Pharm Ltd Phthalazinone derivatives
US7449464B2 (en) 2003-03-12 2008-11-11 Kudos Pharmaceuticals Limited Phthalazinone derivatives
TW200536830A (en) 2004-02-06 2005-11-16 Chugai Pharmaceutical Co Ltd 1-(2H)-isoquinolone derivative
TWI389897B (zh) 2005-02-22 2013-03-21 Chugai Pharmaceutical Co Ltd 1- (2H) -isoquinolinone derivatives
AU2006257815A1 (en) * 2005-06-10 2006-12-21 Bipar Sciences, Inc. PARP modulators and treatment of cancer
GB0521373D0 (en) 2005-10-20 2005-11-30 Kudos Pharm Ltd Pthalazinone derivatives
AU2007292302A1 (en) * 2006-09-05 2008-03-13 Bipar Sciences, Inc. Methods for designing PARP inhibitors and uses thereof
EP2061479A4 (en) * 2006-09-05 2010-08-04 Bipar Sciences Inc FETTIC ACID SYNTHESIS INHIBITED BY PARP HEMMER AND TREATMENT PROCEDURES THEREWITH
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
EP2647376A1 (en) 2007-01-22 2013-10-09 Gtx, Inc. Nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
PL2118074T3 (pl) 2007-02-01 2014-06-30 Resverlogix Corp Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
AU2008299721A1 (en) 2007-09-14 2009-03-19 Astrazeneca Ab Phthalazinone derivatives
UY31603A1 (es) 2008-01-23 2009-08-31 Derivados de ftalazinona
NZ586440A (en) 2008-06-26 2011-07-29 Resverlogix Corp Methods of preparing quinazolinone derivatives
CN102238945B (zh) 2008-10-07 2014-10-29 阿斯利康(英国)有限公司 药物制剂514
JPWO2010061908A1 (ja) 2008-11-28 2012-04-26 中外製薬株式会社 1−(2h)−イソキノロン誘導体
ES2463097T3 (es) 2009-01-08 2014-05-27 Resverlogix Corp. Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
US9238640B2 (en) 2009-03-18 2016-01-19 Resverlogix Corp. Anti-inflammatory agents
NZ596117A (en) 2009-04-22 2014-10-31 Resverlogix Corp Novel anti-inflammatory agents
HUE044986T2 (hu) 2011-11-01 2019-11-28 Resverlogix Corp Orális, azonnali felszabadulású készítmények szubsztituált kinazolinonokhoz
WO2014080290A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Cyclic amines as bromodomain inhibitors
US9765039B2 (en) 2012-11-21 2017-09-19 Zenith Epigenetics Ltd. Biaryl derivatives as bromodomain inhibitors
KR20150096794A (ko) 2012-12-21 2015-08-25 제니쓰 에피제네틱스 코포레이션 브로모도메인 저해제로서의 신규한 헤테로사이클릭 화합물
CN114984016A (zh) 2015-03-13 2022-09-02 雷斯韦洛吉克斯公司 用于治疗补体相关疾病之组合物及治疗方法
US11433074B2 (en) 2017-06-22 2022-09-06 Triact Therapeutics, Inc. Methods of treating glioblastoma
EP3687501A4 (en) 2017-09-29 2021-06-23 Triact Therapeutics, Inc. INIPARIB FORMS AND USES THEREOF

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6518890A (en) 1989-09-26 1991-04-28 Regents Of The University Of California, The 6-amino-1,2-benzopyrones useful for treatment of viral diseases
US5484951A (en) * 1990-10-19 1996-01-16 Octamer, Incorporated 5-iodo-6-amino-6-nitroso-1,2-benzopyrones useful as cytostatic and antiviral agents
US5473074A (en) 1991-10-22 1995-12-05 Octamer, Incorporated Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents-54
US5482975A (en) 1991-10-22 1996-01-09 Octamer, Inc. Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as retroviral inactivating agents, anti-retroviral agents and anti-tumor agents
US5516941A (en) 1991-10-22 1996-05-14 Octamer, Inc. Specific inactivators of "retroviral" (asymmetric) zinc fingers
US5464871A (en) 1993-05-12 1995-11-07 Octamer, Inc. Aromatic nitro and nitroso compounds and their metabolites useful as anti-viral and anti-tumor agents
DE4436127A1 (de) 1994-09-27 1996-03-28 Deutsches Rheumaforschungszent Verwendung von aromatischen Amiden und Säuren zur Behandlung von rheumatischen Erkrankungen
WO1996031206A2 (en) * 1995-04-07 1996-10-10 Warner-Lambert Company Flavones and coumarins as agents for the treatment of atherosclerosis
US10766598B2 (en) 2017-06-14 2020-09-08 The Boeing Company Wing-to-fuselage joints and aircraft including the same

Similar Documents

Publication Publication Date Title
JP2000510751A5 (ja)
JP2000509637A5 (ja)
JP2000507042A5 (ja)
JP2000509942A5 (ja)
JP2000509912A5 (ja)
JP2000509635A5 (ja)
JP2000507433A5 (ja)
JP2000507369A5 (ja)
JP2000509587A5 (ja)
JP2000510793A5 (ja)
JP2000508866A5 (ja)
JP2000508022A5 (ja)
JP2000508841A5 (ja)
JP2000508680A5 (ja)
JP2000509804A5 (ja)
JP2001508699A5 (ja)
JP2000509853A5 (ja)
JP2000510969A5 (ja)
JP2000508836A5 (ja)
JP2000509520A5 (ja)
JP2000510247A5 (ja)
JP2000509818A5 (ja)
JP2000507434A5 (ja)
JP2000508880A5 (ja)
JP2000509754A5 (ja)